TallyHQ
github
Client · LDA

CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

5 filings 29 bills mentioned 1 registrants 5 quarters ~$250,000 reported
Client ID
57911

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
PHA
5
S 1095
Stop STALLING Act
PHA
5
S 1097
Interagency Patent Coordination and Improvement Act of 2025
CPT
5
S 1041
Affordable Prescriptions for Patients Act
CPTMMM
5
S 1040
Drug Competition Enhancement Act
CPT
5
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
CPT
5
S 43
Skinny Labels, Big Savings Act
CPT
5
S 1032
Major Richard Star Act
PHA
5
S 229
DTC Act of 2025
MMM
5
S 1954
Biosimilar Red Tape Elimination Act
CPTPHA
4
S 1785
No Handouts for Drug Advertisements Act
CPTTAX
4
HR 3010
No Handouts for Drug Advertisements Act
CPTTAX
4
HR 3160
PREVAIL Act
CPT
4
S 1533
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes.
CPT
4
S 1546
Patent Eligibility Restoration Act of 2025
CPT
4
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
4
S 2630
Saving NSF’s Workforce Act
PHA
3
S 2276
ETHIC Act
CPT
3
HR 3789
DTC Act of 2025
MMM
3
HR 3269
ETHIC Act
CPT
3
HR 5526
Biosimilar Red Tape Elimination Act
CPTPHA
3
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
CPT
3
S 2658
Medication Affordability and Patent Integrity Act
CPT
3
HR 6485
Skinny Labels, Big Savings Act
CPT
2
HR 1262
Mikaela Naylon Give Kids a Chance Act
PHA
2
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
MMM
1
S 1414
Expedited Access to Biosimilars Act
PHA
1
S 3014
Ensuring Timely Access to Generics Act of 2025
PHA
1
—
119:s:5573
CPT
1

Registrants

Lobbying firms that filed on behalf of this client.

WHITMER & WORRALL, LLC 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.